Congratulations to all our clients on another successful year. Here are some of our news highlights – Bring on 2019!

Awards

Several of our clients have been recognised this year for their progress and contributions to their respective industries.

Check4Cancer 

• Diagnostics provider of the year – Health Investor Awards

Domainex 

• Fastest growing CRO in Europe – FT 1000

Solentim  

• International Trade and Innovation – Queen’s Awards for Enterprise
• 27^th – Deloitte UK Technology Fast 50

Synpromics

• Disruptor – EY Entrepreneur Of The Year, Scotland
• 12^th – Deloitte UK Technology Fast 50

 

Funding

As well as gaining award recognition, this year has seen a number of our clients secure new funding to continue their research and fund further growth.

Domainex

• £118,000 – Innovate UK – Develop a new biophysical screening method for G-protein coupled receptors (GPCRs)

Synpromics

• £235,000 – Innovate UK – Evaluate inducible promoter platform in collaboration with Lonza
• £1.9M – Scottish Enterprise – Expand Synpromics’ R&D programmes in gene regulation for cell and gene medicines

Medherant

• Medicines Manufacturing Grant – Innovate UK – Extend its pilot scale manufacture of patches formulated with its unique TEPI Patch® technology to GMP manufacture for clinical trials

Oppilotech

• Innovate UK – Expand network model of the outer wall of Gram-negative bacteria

Prokarium

• $10million – Saudi, Swedish and Korean Investors– Clinical development of revolutionary thermostable vaccines

ReViral

• $55million – Series B Funding Round – Advance RSV clinical studies into Phase IIa paediatric and adult trials

 

Launches

Three clients have launched new parts of their businesses including a huge scientific/medical research award and new technology to aid scientific reproducibility and collaboration.

British Heart Foundation

• Big Beat Challenge – £30 million award to identify and solve any of the biggest problems in heart and circulatory disease

Riffyn

• Open Access – provides free use of the Scientific Development Environment for next-generation design and publishing of experiments to academics and non-profits

Peerwith

• Peer Science Coin – A new blockchain-based payment token for scientists and academic institutions collaborating on peerwith.com

 

Clinical Trials

Working with a range of life science and technology firms, we see a number of exciting projects and cutting edge research. Two of our clients reached successful clinical trial mile stones this year.

Medherant

• Positive Phase I results – Completion of first clinical safety studies of the TEPI Patch

ReViral

• Positive phase II results – RV521, an oral RSV fusion inhibitor significantly reduced viral load, reduced total mucus weight and reduced clinical symptoms, compared to placebo